Brad Bugdanowitz, a partner in the firm's Life Sciences Group, serves as Chairman of Goodwin’s San Francisco office and Head of the firm’s West Coast Life Sciences practice. He focuses his practice on merger and acquisition transactions, securities offerings and corporate governance. He joined Goodwin in 2008.

Mr. Bugdanowitz works with investment funds and public and private corporations in structuring and executing minority and control investments, acquisitions, dispositions and public and private offerings of equity and debt securities.

Experience

Erfahrung

工作经历

Mr. Bugdanowitz’s experience includes representing:

  • Teva Pharmaceuticals Industries, Ltd. in its acquisition of Auspex Pharmaceuticals, Inc
  • Onyx Pharmaceuticals in its sale to Amgen
  • Roxro Pharma in its sale to Luitpold Pharmaceuticals.
  • Codenomicon Oy in its sale to Synopsys International Limited
  • Royalty Pharma in its acquisition of royalties resulting from commercialization of the drug ibrutinib from Quest Diagnostics, and related collaboration with Aisling Capital and Clarus Ventures
  • ECG Management Consultants, Inc. in its recapitalization by Gryphon Investors
  • Anthera Pharmaceuticals, Inc. in its collaboration with Zenyaku Kogyo Co Ltd., preferred stock and convertible note financings, initial and follow-on public common stock offerings, SEC reporting and governance matters
  • Trigemina Holdings, Inc. in its reinversion transaction from Chile to the United States and related financing transactions
  • Sprout Health Group in its growth equity investment by Housatonic Partners
  • NIKE in its $2 billion aggregate bond offerings, strategic partnership with Dyecoo Textile Systems, B.V., SEC reporting and governance matters
  • Passport Capital in its investment in NEOS GeoSolutions
  • JMI Equity in its investments in SiriusDecisions, BigMachines and Paradigm, Ltd.
  • Altos Therapeutics, Aspire Medical, BioClin Therapeutics, Trigemina Holdings, Radiant Medical, Resonance Medical, Wireless Glue Networks in Preferred equity financing transactions
  • Management group in its management led leveraged buyout of Entek Holdings LLC and subsequent representation of ENTEK in its recapitalization, financing and partnership transactions
  • Outward Bound USA, Inc., Pacific Crest Outward Bound School and the Northwest Outward Bound School in various matters on a pro bono basis.

In The News

In den Nachrichten

在新闻中

Credentials

Anmeldeinformationen

专业资格

Education

J.D., 1996
The University of Chicago Law School
(with honors)
B.A., 1993
University of California, Santa Cruz
(with honors)

Admissions

Bar

California
Get In Touch
In Kontakt kommen
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
Suche Andere Rechtsanwälte
搜寻其他律师